In contrast to the delayed PET imaging acquisition times (i.e., >3 days) required for 89Zr-labeled, HER2-targeting antibodies to ensure sufficient probe accumulation at the target site, adequate clearance from the plasma, and high tumor-to-background ratios47. Here, ERBB2 is linked to neoplasm.